Chargement en cours...
Effect of Abatacept on Immunogenicity of Vaccines in Individuals with Type 1 Diabetes
Abatacept delayed progression of type 1 diabetes (T1D) when administered soon after diagnosis. Its use in T1D is expanding to prevention trials and, therefore, it is important to fully characterize its immunosuppressive effect. We compared antibody responses to trivalent inactivated influenza vaccin...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3803163/ https://ncbi.nlm.nih.gov/pubmed/23962535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.07.086 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|